Company

Ahead together

We unite science, technology and talent to get ahead of disease together.

Hall du bâtiment W23 à GSK Wavre
Close Video

Ahead Together

Getting ahead of disease is one of the most inspiring challenges there is on the planet.

We aim to positively impact the health of 2.5 billion people by the end of the decade.

Getting ahead of disease in
75+
markets.
Careers
Innovation
4
global R&D centres.
R&D approach
Pipeline
71
vaccines and medicines in development.
Innovation
Trust
1st
in the Access to Medicine Index for people in low- to middle- income countries, for the 8th consecutive time.
Responsibility
Performance
46.5 billion
€ in group turnover by 2023.
Investors

Belgium: the heart of GSK Vaccines

Vue aérienne d'une partie du site de GSK à Wavre

Belgium is home to three main vaccine sites for GSK (in Wavre, Rixensart and Gembloux), including the global headquarters of the group's vaccine division. This makes us the largest vaccine manufacturing network in the world.

We ask each of our almost 9,000 employees working in Belgium to share our mission and to think about how they can help all those patients who rely on our products. For that reason, every day our 2,000 scientists research and develop vaccines. And that is why we have been pioneering new solutions allowing us to make our products available to those who need them, wherever they live and whatever their ability to pay.

You might also like

Vue aérienne du bâtiment RIX60 chez GSK Rixensart

At a glance

Belgium hosts 3 main vaccine sites for GSK, including the company's global headquarters of the vaccines division of the group.
Un employé de GSK Wavre sélectionne une fiole

Products

Learn more about our product portfolio.
Deux employés marchent un couloir et discutent

Careers

By bringing together exceptional people in an inclusive environment, we can have a global impact.

Continue to Innovation